SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector-Reference-Cited by-同舟云学术

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector

Published:2020-11 Issue:10 Volume:22 Page:511-514
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Faust Lena,Zimmer Alexandra J.^ORCID,Kohli Mikashmi,Saha Senjuti^ORCID,Boffa Jody^ORCID,Bayot Marlon L.^ORCID,Nsofor Ifeanyi^ORCID,Campos Leonel,Mashamba-Thompson Tivani,Herrera Rosa,Emeka Elom,Shrestha Suvesh,Ugarte-Gil Cesar^ORCID,Katamba Achilles,Pambudi Imran,Bichara David,Calderon Roger I.^ORCID,Ahmadzada Namatullah,Safdar Muhammad Aamir,Nikam Chaitali,dos Santos Lázari Carolina,Hussain Hamidah^ORCID,Win Myint Myint,Than Kyaw Zin,Ahumibe Anthony,Waning Brenda,Pai Madhukar

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference7 articles.

1. Private sector discussion note: COVID-19 testing;Health Systems Governance Collaborative,2020

2. Enabling the private health sector in the national response to COVID-19: six Current Policy Challenges. Geneva;O’Hanlon,2020

3. Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets;Puri;Lancet Global Health,2016

4. New TB tools need to be affordable in the private sector: the case study of xpert MTB/RIF;Ponnudurai;J Epidemiol Glob Health,2018

5. Coronavirus disease (COVID-19) situation report 145;World Health Organization,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the COVID-19 pandemic;PLOS Global Public Health;2024-09-12

2. Socioeconomic and Demographic Effects on SARS-CoV-2 Testing: Evidence From the State of Uttar Pradesh, India;Cureus;2024-05-02

3. Advancements in Rapid and Affordable Diagnostic Testing for Respiratory Infectious Diseases: Evaluation of Aptamer Beacon Technology for Rapid and Sensitive Detection of SAR-CoV-2 in Breath Condensate;Journal of Fluorescence;2023-10-21

4. Biosafety and biosecurity challenges during the COVID-19 pandemic and beyond;Frontiers in Bioengineering and Biotechnology;2023-03-01

5. Limitations of COVID-19 testing and case data for evidence-informed health policy and practice;Health Research Policy and Systems;2023-01-25